|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.15 USD | -1.08% |
|
-6.65% | +22.56% |
| Feb. 23 | Deutsche Bank Adjusts Spyre Therapeutics PT to $55 From $45, Maintains Buy Rating | MT |
| Feb. 20 | Top Midday Gainers | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.08% | -6.65% | +14.32% | +20.03% | +22.56% | +95.85% | +301.70% | -77.85% | - | 3.15B | |
| -0.61% | -5.35% | -10.55% | -19.30% | -13.20% | +7.61% | +93.47% | +160.33% | +6,097.21% | 44.16B | |
| +0.92% | -4.81% | -4.63% | +3.21% | +2.93% | +49.57% | +13.78% | -17.42% | - | 40.5B | |
| -2.40% | -6.16% | -6.49% | -31.31% | -19.48% | +86.79% | +581.90% | +267.51% | +1,025.54% | 30.21B | |
| -0.44% | -7.92% | -4.80% | +5.45% | +6.62% | -8.42% | -22.84% | +5.51% | - | 25.47B | |
| +2.54% | -9.65% | -3.56% | +11.40% | +15.59% | +54.31% | -36.52% | -59.40% | - | 19.22B | |
| -2.62% | -6.49% | -11.72% | -14.94% | -14.73% | +5.33% | -32.35% | -9.10% | +110.79% | 16.5B | |
| +5.20% | +0.37% | +6.34% | -13.54% | -5.04% | +49.24% | +146.95% | +126.61% | - | 12.64B | |
| +1.14% | -8.92% | +0.80% | -17.48% | -13.61% | -20.43% | +987.05% | +166.49% | +128.94% | 11.72B | |
| +4.43% | -0.31% | -8.74% | -16.04% | -1.53% | +53.50% | - | - | - | 11.51B | |
| +0.64% | -5.71% | -5.36% | -6.35% | -5.21% | +8.73% | +152.25% | +86.05% | +910.83% | 10.79B | |
| -1.48% | +0.19% | -9.37% | -25.03% | -25.67% | +31.65% | +59.76% | +272.23% | - | 9.93B | |
| -3.03% | -19.41% | -2.51% | +5.63% | -26.78% | - | - | - | - | 9.11B | |
| -3.24% | -11.35% | +43.31% | +278.60% | +337.88% | +189.97% | +392.61% | - | - | 8.91B | |
| -5.94% | -5.45% | -7.28% | -2.64% | -9.90% | +238.54% | +94.28% | -13.30% | +1,281.52% | 8.38B | |
| +1.79% | -3.97% | +5.59% | +27.56% | +28.50% | -20.75% | +43.77% | +149.54% | - | 8.53B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +62.72% | +226.27% | - | 8.19B | |
| +1.31% | -3.59% | -3.46% | +36.06% | +48.51% | +29.75% | +56.96% | +534.91% | +372.31% | 8.14B | |
| -0.72% | -2.49% | -4.04% | -9.30% | -1.17% | +36.29% | +256.69% | - | - | 7.82B | |
| -2.86% | -2.91% | -3.10% | -8.01% | -4.93% | +39.61% | +54.38% | +206.96% | +863.48% | 7.44B | |
| Average | -0.04% | -5.10% | -0.76% | +11.20% | +16.07% | +48.80% | +178.14% | +126.58% | +1,348.83% | 15.12B | |
| Weighted average by Cap. | -0.02% | -5.17% | -3.58% | +1.78% | +6.51% | +40.68% | +160.12% | +110.02% | +2,429.29% |
- Stock Market
- Equities
- SYRE Stock
- Sector Spyre Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
